Vidcast:  https://www.instagram.com/p/CuAXkKKuS6R/

The FDA has approved the oral medicine fezolinetant, branded as Veozah, as an effective treatment for severe vasomotor symptoms brought on by menopause.  This age is a neurokinin 3 receptor antagonist that effectively shields the receptor that controls body temperature.  The pill should be taken once a day, each day at the same time.  The drug’s effectiveness and safety were determined in two randomized, controlled, double-blinded trials.

https://www.fda.gov/news-events/press-announcements/fda-approves-novel-drug-treat-moderate-severe-hot-flashes-caused-menopause

#hotflashes #menopause #Veozah #fezolinetant